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Abstract: Background: Roma health has not been studied systematically. Thus far, it has been shown
that Roma compared to non-Roma have a significantly higher likelihood of getting end-stage renal
disease and that their chances for survival on dialysis are lower. Evidence is lacking regarding
morbidity between Roma and non-Roma. The aim was to compare the health status of dialyzed
Roma and non-Roma using the Charlson comorbidity index (CCI). All Slovak dialysis centers for
adults were asked to fill in a questionaire with demographic and clinical data, including comorbidity.
Cross-sectional analysis of 2082 patients with an average age of 63.8 ± 13.8 years was performed.
Comorbidity was expressed as the CCI, and ethnic differences were calculated. Linear regression was
performed to adjust for differences in gender and age in both ethnic groups. Roma represented 13.0%
of the whole dialyzed population (n = 270). Comorbidity expressed as CCI was significantly lower in
the Roma population (p < 0.001). After adjusting for gender and age, ethnicity failed to be associated
with the CCI in the linear regression analysis (p = 0.965, variance of the model—adjusted R2 38.6%).
The health status of dialyzed Slovak Roma does not differ cross-sectionally when adjusted for age
and gender from the health status of dialyzed non-Roma.
Keywords: Roma; health; dialysis; Slovakia
1. Introduction
Roma represent the largest minority in Slovakia [1]; however, their health has not been studied
systematically. A higher prevalence of some chronic diseases, such as diseases of the cardiovascular
system, diabetes mellitus, obesity as well as kidney disease, has been reported in the Roma
minority [2–7]. So far, Roma compared to non-Roma have been shown to have a 2.4-times higher
likelihood of getting end-stage renal disease (ESRD) [3] and that their chances for survival on dialysis
are lower [8]. Sudzinova found a similar result in a survival study on cardiovascular disease [5].
While some part of the higher risk for ESRD might be explained by different occurrence of primary
nephropathies [9], differences in comorbidity potentially explaining the shorter dialysis survival of
Roma have never been identified.
The Charlson comorbidity index (CCI) has been shown to be an accurate tool for assessing health
status and survival prediction of diseased individuals; this tool has also been validated in dialyzed
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patients [10,11]. A study by Rattanasompattikul et al. [12] showed the CCI to be a robust and linear
predictor of mortality, particularly in non-African Americans. The CCI has never been applied to
(dialyzed) Roma. The aim of this study was to compare the health status of dialyzed Roma and
non-Roma using the CCI.
2. Materials and Methods
2.1. Patients and Procedure
All Slovak dialysis centers for adults were asked to fill in a questionaire with the following
questions regarding patients: (a) demographic data—age, gender, ethnicity; (b) clinical data related to
dialysis—date of dialysis start, primary nephropathy, dialysis modality, vascular access, weight, height,
diabetes mellitus (DM); (c) complications and other diagnoses—complications of DM (other than renal
failure), status after myocardial infarction and cerebrovascular accident, dementia, hemiplegia, chronic
heart failure, chronic obstructive lung disease, solid tumor, leukemia, malignant lymphoma, ulcer
disease, hepatopathy, AIDS, and connnective tissue disease.
We performed this cross-sectional study in June and July 2017, with 39 out of 77 (response 50.6%)
units participating in our study. We obtained data on 2082 patients (average age of 63.8 ± 13.8 years,
59.5% males, dialysis history of 4.6 ± 5.5 years). The only figure we had regarding the number of
patients is that at the end of December 2016 there were 3453 prevalent dialyzed patients in the whole
country (coverage of 60.2%) [13].
2.2. Measures
Body mass index (BMI) was calculated as the weight in kilograms divided by the square of the
height in meters.
To measure the comorbidity pattern of the patients we used the CCI; after scoring, the index was
calculated [10].
We instructed that ethnicity be measured as follows: self-determination of ethnicity was compared
to the determination judged by a physician, and in case of a mismatch the opinion of the head-nurse
was decisive. This was necessary, as the self-determination of Roma in the last national census in 2011
showed a massive underestimation of the percentage of Roma (2.0%). Reliable estimates of Roma in
Slovakia are several-fold higher [1].
2.3. Statistical Analyses
First, the Chi-squared test and Student’s t-test were used. Second, linear regression was performed
to adjust for differences in gender and age in both ethnic groups. Analysis was considered statistically
significant at the level of p < 0.05. The statistical software SPSS 23 (IBM Corp., Armonk, NY, USA)
was used.
3. Results
Out of 2082 patients from 39 dialysis units, 74% were being treated by hemodiafiltration (HDF),
23% hemodialysis (HD) and 3% were on peritoneal dialysis (PD). Seventy percent had an arteriovenous
fistula (AVF), and 30% had a central venous catheter. The spectrum of diagnoses causing ESRD was as
follows: diabetic nephropathy 34%, chronic tubulointerstitial nephritis 18%, chronic glomerulonephritis
13%, vascular nephrosclerosis 12%, others and unknown 10%, chronic pyelonephritis 6%, polycystic
kidney disease 6% and vasculitis 1%. Ethnic differences in independent variables are shown in Table 1.
Roma represented 13.0% of the whole dialyzed population (n = 270, the number of Roma in
each dialysis unit varied from 0 to sometimes a very high percentage, up to 49%). Ethnic differences
are presented in Table 2. Comorbidity expressed as the CCI was significantly lower in the Roma
population (p < 0.001). After adjusting for gender and age, ethnicity failed to be associated with the
CCI in the linear regression analysis (p = 0.965, variance of the model—adjusted R2 38.6%; Table 3).
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Table 1. Primary renal diseases causing end-stage renal disease (ESRD) by ethnicity.
Variable Roma Non-Roma Difference
Diabetic nephropathy (%) 35.9 33.5 n.s.
Chronic tubulointerstitial nephritis (%) 14.4 18.7 n.s.
Chronic glomerulonephritis (%) 13.3 13.4 n.s.
Vascular nephrosclerosis (%) 11.1 12.4 n.s.
Others and unknown (%) 15.9 8.8 p = 0.001
Chronic pyelonephritis (%) 6.7 6.1 n.s.
Polycystic kidney disease (%) 1.9 6.0 p = 0.007
Vasculitis (%) 0.7 1.2 n.s.
n.s.—non-significant.
Table 2. Characteristics of the sample.
Variable Roma Non-Roma Difference
Age (years) 55.0 ± 14.3 65.2 ± 13.3 p < 0.001
Dialysis history (years) 4.1 ± 4.3 4.7 ± 5.7 p = 0.034
Male gender (%) 53.0 61.0 p = 0.014
AVF (%) 68.9 69.7 p = 0.831
HD/HDF/PD (%) 38.7/60.2/1.1 20.3/75.8/3.9 p < 0.001
Weight (kg) 77.1 ± 22.4 76.1 ± 18.5 p = 0.414
Height (cm) 161.6 ± 11.5 167.3 ± 10.4 p < 0.001
BMI (kg/m2) 29.3 ± 7.7 27.1 ± 5.9 p < 0.001
CCI 5.92 ± 2.7 7.25 ± 2.9 p < 0.001
CCI: Charlson comorbidity index.
Table 3. Linear regression.
Model B 95% CI Difference
Ethnicity −0.007 −0.321; 0.308 p = 0.965
Gender 0.303 0.091; 0.516 p = 0.005
Age 0.132 0.125; 0.140 p < 0.001
B—standardized coefficient; CI—confidence interval.
4. Discussion
We compared the comorbidity of Roma and non-Roma using the CCI in the Slovak dialyzed
population; this is the first study in this field. We found that the CCI was significantly lower in
the Roma population; however, after adjusting for the younger age of the Roma, the differences
disappeared, showing that cross-sectionally, in patients surviving on dialysis, there are no significant
differences in the health status of Roma and non-Roma.
Roma ethnicity was shown to be an independent risk factor for mortality [8]. Similar to our
results, the study of Gadalean et al. also showed a significantly younger age of dialyzed Roma and a
shorter dialysis history. If the CCI is also a good predictor of mortality in the Roma ethnic group [12],
then a higher CCI in Roma might be expected, which failed to be true in our sample. The explanation
might be that patients with higher CCI are likely to die sooner and are therefore no longer present in
our cross-sectional study, leading to the not-significant difference in CCI between ethnic groups.
Ethnic differences in our study were also identified in the spectrum of diagnoses. “Others and
unknown” were significantly more common in Roma (p = 0.001). Roma more frequently appear at
dialysis units without previous follow-up by a nephrologist [14], which hampers precise diagnostics
of their primary nephropathy and contributes to a higher risk of ESRD. Studies in other fields of
medicine have similarly shown late referral of Roma [4,15], which adds to the higher morbidity of a
specific disease in Roma. In our study, a comparison of the occurrence of diabetic nephropathy by
ethnicity showed not-significant differences, and a similar proportion of patients with DM as well as
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its types separately (DM1 and DM2) were found not to differ in the mentioned subpopulations. The
same holds true for complications of DM. This finding is in contrast with the higher prevalence of
DM in the general Roma population in Slovakia as well as in the general population of inhabitants
of India [6,16]. The Indian subcontinent is assumed to be the place of origin of the Roma. Our
finding that the occurrence of DM does not differ between Roma and non-Roma can be explained by
selection and survival bias of dialyzed patients. Polycystic kidney disease (PKD) was significantly less
common among dialyzed Roma. This may be explained by the nature of this disease, which appears
in family clusters. This seems to be in contrast to the situation in Hungary, where clusters of PKD
were described as being more common among Roma with chronic kidney disease [17]—underlying an
effect of a founder.
Significant differences by ethnicity were found in the modalities of dialysis; however, we may only
speculate regarding the possible causes. The Slovak dialysis market is almost exclusively private, but it
functions as a publicly organized system, accessible for every Slovak equally. The technical equipment
and offered modalities vary dramatically among dialysis centers, however. In our questionnaire we
did not ask for indications regarding any specific modality, so we can only guess as to the reason
behind these differences. On the other hand, we found no significant ethnic differences in vascular
access, which indirectly argues against discrimination. Ethnic comparisons of dialysis modalities are
rarely described in the literature, i.e., in the U.S. renal data system (USRDS) no significant difference
was found [18].
4.1. Strengths and Limitations
This is the first epidemiologic study in the Roma minority describing comorbidity using the
CCI of the dialyzed population and representing more than half of the dialyzed Slovak population.
However, some limitations should be mentioned. Although we did not have complete data on the
whole dialyzed population, the participation of dialysis units from all parts of the country with a
higher/lower share of Roma was only influenced by chance. This potential selection of the dialyzed
population hampered any ethnic comparison of diabetes mellitus occurrence. Thus, this cross-sectional
analysis, however national in its design, does not allow for causal interpretations.
4.2. Implications
More attention should be paid to early stages of chronic kidney disease in Roma to prevent
premature ESRD. Future studies should focus on ethnic differences in dialysis modalities to explain
possible causes of these differences and on earlier mortality in the Roma patients compared
to non-Roma.
5. Conclusions
Cross-sectionally when adjusted for age and gender, no significant differences in health status
expressed as the CCI of the dialyzed Roma and non-Roma in Slovakia were identified. However, the
younger age of the dialyzed Roma and their shorter stay on dialysis suggests a higher mortality among
Slovak dialyzed Roma. Longitudinal studies are needed to show mortality in (Slovak) Roma patients.
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